The Role of the Medicines Patent Pool in Stimulating the Development and Availability of Global Health Medicines. Full article at the Lexxion WebsiteContinue Reading →
The release of the 2014 GIPC IP Index was widely covered in international media. Please find below some of the news stories that have appeared since the launch of the Index on January 29 2014.
Dr David Torstensson, Partner with Pugatch Consilium, is speaking at the international launch of the 2013 GIPC IP Index at the US Chamber of Commerce in Washington DC, USA. Pugatch Consilium has developed the GIPC IP Index in partnership with the US Chamber of Commerce’s Global Intellectual Property Center. The Index is a one-of-a-kind instrument that benchmarks and measures the national IP environment in 25 countries.
The launch of the 2013 Index will take place on January 29 2014 starting at ...Continue Reading →
The case of Teva requires us to revise our thinking about national champions and national interests;
Prof. Meir Perez Pugatch addresses the current situation with Teva pharmaceuticals – the biggest generics company in the world – in Israel and how it has been impacted by the patent expiration of Copaxon. Full article at Pharmaphorum Media
Earlier this month, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its 16th Annual European Congress, in Dublin. ISPOR is a non-profit organization founded in 1995 for educational and scientific purposes. The cylinder-shaped Convention Centre building overlooking the River Liffey served as the venue for an impressive event which featured over 1800 presentations and was visited by circa 3800 people from a variety of professional fields including health technology developers and assessors, regulators, health economists, healthcare policymakers, academia, ...Continue Reading →
Prof. Meir Pugatch presenting at the Montréal InVivo/LSO – Breakfast round-table IP protection in Ottawa
Full video at: http://www.youtube.com/watch?v=IkmC5DQ5b88&feature=youtu.beContinue Reading →
As the knowledge economy becomes a more fundamental part of the global economy, so grows the interest in, and proliferation of, policies devoted to strengthening innovation and the knowledge base. But it is not always an easy or straightforward process for policymakers’ knowledge to keep pace with the speed of innovation in ‘real world’ business models, methods and practices.
This week, our Founder and MD, Professor Meir Pugatch, wearing his ‘other hat’ as a visiting Professor at Maastricht University, took a ...Continue Reading →
Prof. Pugatch will be moderating the regulatory panel on: Government support, strategies and policies for promoting R&D, at the 4th Annual “Innovative Drug Research & Development in Russia” Conference, 19 November 2013Continue Reading →
This week, Pugatch Consilium’s Founder and MD, Professor Meir Pugatch, will be addressing a series of gatherings in Montreal and Ottawa to discuss the issue of competitiveness in the Canadian life sciences and, in particular, looking at the role of intellectual property protection in facilitating innovation. At the events, co-hosted by Montreal InVivo and Life Sciences Ontario, Professor Pugatch will outline his thoughts in front of an audience of distinguished guests including Canada’s minister of higher education, sciences and technology.
Drug ...Continue Reading →